I agree that this site is using cookies. You can find further informations here.
X
Vasileiou, Spyridoula
34  results:
Search for persons X
?
1

Phenotypic and Functional Characterization of Posoleucel, a..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Velazquez, Yovana...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S427-S428 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Final Outcomes from a Phase 2 Trial of Posoleucel in Alloge..:

Dadwal, Sanjeet Singh ; Bansal, Rajat ; Schuster, Michael...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
3

Phenotypic and functional characterization of posoleucel, a..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Velazquez, Yovana...
Cytotherapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

ALVR106, an Off-the-Shelf, Multivirus-Specific T-Cell Thera..:

Nikiforow, Sarah ; Horowitz, Mitchell ; McCarty, John M....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S83-S84 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Assessment of the Cytolytic Potential of a Multivirus-Targe..:

Koukoulias, Kiriakos ; Papayanni, Penelope G. ; Jones, Julia...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S438 , 2024
Link: https://doi.org/10.1016/..
 
?
6

T cell immune profiling of respiratory syncytial virus for ..:

Papayanni, Penelope Georgia ; Koukoulias, Kiriakos ; Kuvalekar, Manik...
British Journal of Haematology.  202 (2023)  4 - p. 874-878 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Assessment of the cytolytic potential of a multivirus-targe..:

Koukoulias, Kiriakos ; Papayanni, Penelope G. ; Jones, Julia...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

Final Clinical Outcomes from a Phase 2 Trial of Posoleucel,..:

Dadwal, Sanjeet Singh ; Young, Jo-Anne H. ; Schuster, Michael W...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S65-S66 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Exploring hepatitis B virus as an immunotherapeutic target ..:

Lulla, Suhasini ; Chang, Tsung-Yen ; Vasileiou, Spyridoula...
Journal of Hepatology.  77 (2022)  - p. S839 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Multi-antigen-targeted T-cell therapy to treat patients wit..:

Hoyos, Valentina ; Vasileiou, Spyridoula ; Kuvalekar, Manik...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211071 , 2022
Link: https://doi.org/10.1177/..
 
?
11

Longitudinal analysis of the evolution of cellular immunity..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Velazquez, Yovana...
Haematologica.  108 (2022)  7 - p. 1934-1939 , 2022
Link: https://doi.org/10.3324/..
 
?
12

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tu..:

Naik, Swati ; Vasileiou, Spyridoula ; Tzannou, Ifigeneia...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S24 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALV..:

Vasileiou, Spyridoula ; Hill, LaQuisa ; Kuvalekar, Manik...
Haematologica.  108 (2022)  7 - p. 1840-1850 , 2022
Link: https://doi.org/10.3324/..
 
?
14

Safety and Tolerability of Administering Leukemia-Specific ..:

Doherty, Erin E ; Omer, Bilal ; Vasileiou, Spyridoula...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S223 , 2022
Link: https://doi.org/10.1016/..
 
?
15

37. Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T Cells ..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Workineh, Aster...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S27-S27 , 2021
Link: https://doi.org/10.1093/..
 
1-15